Low dose EGCG treatment beginning in adolescence does not improve cognitive impairment in a Down syndrome mouse model.

Saved in:
Bibliographic Details
Title: Low dose EGCG treatment beginning in adolescence does not improve cognitive impairment in a Down syndrome mouse model.
Authors: Stringer, Megan1, Abeysekera, Irushi2, Dria, Karl J.3, Roper, Randall J.2 rjroper@iupui.edu, Goodlett, Charles R.1
Source: Pharmacology, Biochemistry & Behavior. Nov2015, Vol. 138, p70-79. 10p.
Database: Academic Search Ultimate
Description
ISSN:00913057
DOI:10.1016/j.pbb.2015.09.002